COVID-19 and Interacting Public Health Threats in Europe During 2020-2025: A Narrative Review.

Publication date: Jun 02, 2026

Between 2020 and 2025, Europe has faced multiple interacting public health threats shaped by and following the COVID-19 pandemic. Alongside COVID-19, the region experienced other infectious disease events, including monkeypox, measles resurgence, legionellosis and acute hepatitis of unknown origin in children. At the same time, non-communicable disease burdens, including obesity, type II diabetes mellitus, disruption of chronic disease care, mental health disorders and increased problematic digital use, intensified during and after the pandemic period. Antimicrobial resistance (AMR) remained a major cross-cutting threat because it undermines the effective treatment of infections and weakens emergency preparedness. This narrative review synthesizes peer-reviewed articles and selected reports from international organizations for the 2020-2025 period, using COVID-19 as the organizing context for examining interconnected infectious, chronic and system-level threats. Across these topics, recurring themes included vaccination gaps, fragmented surveillance, disruption of routine care, health system inequities, misinformation and insufficient preparedness for cross-border threats. The review supports integrated surveillance, continuity plans for essential services, stronger vaccination and risk-communication strategies and sustained AMR stewardship within a One Health framework. Coordinated action across public health, primary care, mental health and chronic disease policy is essential for future resilience.

Open Access PDF

Concepts Keywords
Covid antimicrobial resistance
Diabetes COVID-19
Monkeypox epidemic
Surveillance Europe
infectious disease
non-communicable diseases
outbreak
pandemic
public health
surveillance
vaccination

Semantics

Type Source Name
disease MESH COVID-19
disease MESH infectious disease
pathway REACTOME Infectious disease
disease MESH monkeypox
disease MESH measles
pathway KEGG Measles
disease MESH legionellosis
pathway KEGG Legionellosis
disease MESH non-communicable disease
disease MESH obesity
pathway KEGG Type II diabetes mellitus
disease MESH chronic disease
disease MESH infections
disease MESH emergency
disease MESH included
disease MESH diabetes mellitus
disease MESH mental disorders
drug DRUGBANK Aspartame
disease MESH polio
disease MESH cardiovascular
disease MESH proctitis
disease MESH cam
disease MESH zoonotic diseases
drug DRUGBANK Water
disease MESH Legionnaires’ disease
disease MESH jaundice
disease MESH vomiting
disease MESH abdominal pain
disease MESH hepatitis
disease MESH syndrome
disease MESH adenovirus infection
disease MESH anxiety
disease MESH ers
disease MESH eating disorders
disease MESH renal failure
disease MESH mental deterioration
disease MESH tar
disease MESH dis
disease MESH Pain
drug DRUGBANK Sulfasalazine
disease MESH Weight Gain
disease MESH Pediatric Obesity
drug DRUGBANK Nadide
drug DRUGBANK Ethanol
disease MESH injury

Original Article

(Visited 4 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *